To help guarantee a successful lab launch, this How to Guide breaks down the licensing requirements every lab owner should consider before opening their operation.
LSD was the twenty-fifth compound in a series produced by Dr. Albert Hofmann, a natural products chemist at Sandoz AG Pharmaceutical Company in Swizelrand in 1938, but initial screening failed to reveal any activity of interest. With renewed interest in the potential of psychedelic drugs for the treatment of mental health disorders international research interest in LSD is growing rapidly.
Whether testing under recreational or medicinal legislation, there are multiple options that should suit your application. But how do you choose the right method for the right test? And what compromises should you expect to make and where?
These well-known compounds have moved past decades of stigma to become well-studied therapeutics either approved or in trial to treat mental health conditions such as major depression and post-traumatic stress disorder.
To help avoid the common pitfalls of the technique, Dr Kimberly Ross, chief science officer at Peak Compliance, and Julie Kowalski of JA Kowalski Science Support outline where LC-MS can go wrong in this original Analytical Cannabis list.
There’s a lot of buzz around good manufacturing practices (GMP) in the cannabis industry. But why are they so needed? And how are they best implemented? Dr Kimberly Ross, chief science officer at Peak Compliance, answers all these questions and more in this original Analytical Cannabis list.
When it comes to the testing of cannabis flower and concentrates, sampling is vital. But many issues can present themselves when collecting a representative sample and avoiding contamination. So, how can they be avoided?